{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:41:38Z","timestamp":1791726098709,"version":"4.3.4"},"reference-count":121,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2021,4,3]]},"DOI":"10.1080\/13543784.2021.1865308","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T21:23:15Z","timestamp":1608067395000},"page":"429-438","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":35,"title":["Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy"],"prefix":"10.1080","volume":"30","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumera","family":"Ilyas","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.157"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0310-z"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00280-x"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2018.01.007"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03112"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.02.009"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.05.006"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8458"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.401"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2731"},{"key":"e_1_3_4_14_1","first-page":"115","article-title":"Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells","volume":"13","author":"Techasen A","year":"2012","unstructured":"Techasen A, Loilome W, Namwat N, et al. Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. Asian Pac J Cancer Prev. 2012;13(Suppl):115\u2013118.","journal-title":"Asian Pac J Cancer Prev"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01614.x"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76452"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.169"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137110"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12527"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81603"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121623109"},{"key":"e_1_3_4_22_1","article-title":"Targeting macrophage checkpoint inhibitor SIRPa for anticancer therapy","author":"Liu J","year":"2020","unstructured":"Liu J, Xavy S, Mihardja S, et al. Targeting macrophage checkpoint inhibitor SIRPa for anticancer therapy. JCI Insight. 2020 May;;5(12):e134728.","journal-title":"JCI Insight"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.10.007"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.11.013"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.01.014"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0297"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0022-x"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.689"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03070"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3A0414-210R"},{"issue":"1","key":"e_1_3_4_31_1","first-page":"99","article-title":"Circulating myeloid-derived suppressor cells in patients with pancreatic cancer","volume":"15","author":"Xu XD","year":"2016","unstructured":"Xu XD, Hu J, Wang M, et al. Circulating myeloid-derived suppressor cells in patients with pancreatic cancer. Hbpd Int. 2016 Feb;15(1):99\u2013105.","journal-title":"Hbpd Int"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4625"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1234565"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306271"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.12.026"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0102"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.01.038"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0210-z"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403134"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.03.016"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.015"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21777"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.02.008"},{"issue":"14","key":"e_1_3_4_44_1","first-page":"5228","article-title":"Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas","volume":"9","author":"Freedman RS","year":"2003","unstructured":"Freedman RS, Vadhan-Raj S, Butts C, et al. Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas. Clin Cancer Res off J Am Assoc Cancer Res. 2003 Nov 1;9(14):5228\u20135237.","journal-title":"Clin Cancer Res off J Am Assoc Cancer Res"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.23.3883"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062518-045435"},{"issue":"3","key":"e_1_3_4_47_1","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4049\/jimmunol.163.3.1289","article-title":"Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo","volume":"163","author":"Borges L","year":"1999","unstructured":"Borges L, Miller RE, Jones J, et al. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo. J Immunol. 1999 Aug 1;163(3):1289\u20131297.","journal-title":"J Immunol"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2014.11.006"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0061-z"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0152"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01354"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0511-1"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21964"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2018.06.521"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12853"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.06.023"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1251102"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.610"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.10321"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.01.067"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0144-8"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.13238"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11949"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21376"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2019.08.08"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4082"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-016-0474-1"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0420-8"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.05.026"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000609"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.08.016"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.04.014"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2014.10.007"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1131"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-13"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2130"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.12.004"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.05.031"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"issue":"1","key":"e_1_3_4_80_1","first-page":"445","article-title":"Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl(4)-induced liver fibrogenesis mouse model","volume":"7","author":"\u00d6zt\u00fcrk Akcora B","year":"2017","unstructured":"\u00d6zt\u00fcrk Akcora B, Storm G, Prakash J, et al. Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl(4)-induced liver fibrogenesis mouse model. Sci Rep-Uk. 2017;7(1):445.","journal-title":"Sci Rep-Uk"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3867198"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.270"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0744-7"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.7.4630"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0125"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.10.037"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2130"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300643"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27687"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001654"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.039"},{"issue":"2","key":"e_1_3_4_92_1","article-title":"Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4+ T cell-dependent manner","volume":"2020","author":"Ware MB","year":"2020","unstructured":"Ware MB, McQuinn C, Zaidi MY, et al. Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4+ T cell-dependent manner. bioRxiv. 2020;2020(2):07.939199.","journal-title":"bioRxiv"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.11.006"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2019.10.005"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.1.593"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14267"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24588"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26384"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26585"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-4785-8"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604129"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/84635"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800985"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.08.007"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23049"},{"key":"e_1_3_4_106_1","doi-asserted-by":"crossref","unstructured":"Kim RD Sanoff HK Poklepovic AS et al. A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer. Cancer. 2020 May 26; Aug 1;126(15):3464\u20133470","DOI":"10.1002\/cncr.32964"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.119"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81130"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2016.11.003"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.009"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00093.2010"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.043"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27050"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29291"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030721"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28735"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24711"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33013"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0930"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.2814"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23638"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.11.021"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2021.1865308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T03:49:51Z","timestamp":1732592991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2021.1865308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,3]]}},"alternative-id":["10.1080\/13543784.2021.1865308"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2021.1865308","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}